New Invention: Discovery of a new target gene and gene therapy for cervical cancer

An inventor from Saudi Arabia presented at the Geneva Invention Fair 2013 the invention: "Discovery of a new target gene and gene therapy for cervical cancer".

The inventor discovered that Aurora A Kinase, a gene that plays an essential  role in cytokinesis where the cell divides into the two new identical daughter cells, is higly essential for survival of the cancerous cells. The inventor explored that the depletion of the Auroara A Gene by small interfering RNA (si9RNA) caused the cancer cell to undergo apoptosis. This discovery led to the notion of using a new drug  to inactivate the activity of the protein of the Aurora A Gene. Using  animal models with cervical cancer, the drug was highly effective and completely cured the cancer using one circle of the drug  for 10 consecutive days. No cancer occurrence was observed at least 50 days  post–treatment. 

The application of the drug is for any stage of the disease. This discovery should proceed into clinical trials within the next few months.

This invention has a potential for broad international application and its application can have very positive  effects in cervical cancer  treatment. The inventor is interested in commercialization of the patented invention, seeking appropriate interested manufacturer. EPO Patent Registration Services and Consulting GmbH has made direct contact with the inventor and has information about the invention. Interested parties can contact EPO Patent Registration at: